CV conditions and treatments
Session: Poster Session A
Anna Ostropolets, MD, PhD (she/her/hers)
Associate Director
Johnson and Johnson Innovative Medicine, United States
Joel N. Swerdel, PhD MS MPH (he/him/his)
Director
Johnson and Johnson Innovative Medicine
Titusville, United States
Melanie H. Jacobson, PhD, MPH (she/her/hers)
Associate Director
Johnson and Johnson Innovative Medicine, United States